Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and methoxy-morpholinyl-doxorubicin

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with methoxy-morpholinyl-doxorubicin in 1 studies

Compound Research Comparison

Studies
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)
Trials
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)
Recent Studies (post-2010)
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)
Studies
(methoxy-morpholinyl-doxorubicin)
Trials
(methoxy-morpholinyl-doxorubicin)
Recent Studies (post-2010) (methoxy-morpholinyl-doxorubicin)
38005068

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Vries, EG; Meijer, C; Mulder, NH; van der Graaf, WT1

Other Studies

1 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and methoxy-morpholinyl-doxorubicin

ArticleYear
The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Resistance; Drug Resistance, Multiple; Humans; Lung Neoplasms; Tumor Cells, Cultured

1995